Inhibitors of undecaprenyl pyrophosphate synthase

Details for Australian Patent Application No. 2007276804 (hide)

Owner Novartis AG

Inventors Lee, Kwangho; Hurley, Timothy Brian; Wattanasin, Sompong; Peukert, Stefan

Agent Davies Collison Cave

Pub. Number AU-A-2007276804

PCT Pub. Number WO2008/014307

Priority 60/820,367 26.07.06 US

Filing date 25 July 2007

Wipo publication date 31 January 2008

International Classifications

A61K 31/00 (2006.01)

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/014307 Priority application(s): WO2008/014307

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007276808-Inhibitors of undecaprenyl pyrophosphate synthase

2007276793-Composition and method for treatment of tumors